CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

Press releases

05/16/2022

CHEPLAPHARM acquires rights to CMV medicine

more chevron_right
Press releases

04/29/2022

CHEPLAPHARM continues profitable growth track in 2021 as well

more chevron_right
Press releases

03/21/2022

Significant and sustainable site expansion

more chevron_right
Press releases

03/01/2022

CHEPLAPHARM acquires additional oncology drugs

more chevron_right
Press releases

02/23/2022

Jens Rothstein hands over his CFO role to Kia Parssanedjad

more chevron_right
Investor Relations

02/11/2022

CHEPLAPHARM announces successful pricing of Term Loan B

more chevron_right
Archive Press releases

11/19/2021

CHEPLAPHARM continues strong Growth

more chevron_right
Press releases

10/13/2021

CHEPLAPHARM signed deal

more chevron_right
Press releases

06/16/2021

CHEPLAPHARM invests in portfolio of anti-infectives

more chevron_right
Press releases

05/04/2021

CHEPLAPHARM continues on the road to success

more chevron_right
Back to top expand_less